{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:12:22Z","timestamp":1775707942693,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ZonMw","award":["40-41500-98-9002"],"award-info":[{"award-number":["40-41500-98-9002"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Model validation procedures are crucial when population pharmacokinetic (PK) models are used to develop dosing algorithms and to perform model-informed precision dosing. We have previously published a population PK model describing the PK of gentamicin in term neonates with perinatal asphyxia during controlled therapeutic hypothermia (TH), which showed altered gentamicin clearance during the hypothermic phase dependent on gestational age and weight. In this study, the predictive performance and generalizability of this model were assessed using an independent data set of neonates with perinatal asphyxia undergoing controlled TH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The external data set contained a subset of neonates included in the prospective observational multicenter PharmaCool Study. Predictive performance was assessed by visually inspecting observed-versus-predicted concentration plots and calculating bias and precision. In addition, simulation-based diagnostics, model refitting, and bootstrap analyses were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The external data set included 323 gentamicin concentrations of 39 neonates. Both the model-building and external data set included neonates from multiple centers. The original gentamicin PK model predicted the observed gentamicin concentrations with adequate accuracy and precision during all phases of controlled TH. Model appropriateness was confirmed with prediction-corrected visual predictive checks and normalized prediction distribution error analyses. Model refitting to the merged data set (n = 86 neonates with 935 samples) showed accurate estimation of PK parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The results of this external validation study justify the generalizability of the gentamicin dosing recommendations made in the original study for neonates with perinatal asphyxia undergoing controlled TH (5 mg\/kg every 36 or 24 h with gestational age 36\u201341 and 42 wk, respectively) and its applicability in model-informed precision dosing.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001166","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T08:09:24Z","timestamp":1706602164000},"page":"376-383","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Predictive Performance of a Gentamicin Pharmacokinetic Model in Term Neonates with Perinatal Asphyxia Undergoing Controlled Therapeutic Hypothermia"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-1381","authenticated-orcid":false,"given":"Marlotte A. A.","family":"van der Veer","sequence":"first","affiliation":[{"name":"Department of Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo R.","family":"de Haan","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda G. W.","family":"Franken","sequence":"additional","affiliation":[{"name":"Department of Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floris","family":"Groenendaal","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Wilhelmina Children's Hospital, Utrecht, The Netherlands;"},{"name":"UMC Utrecht Brain Center, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.","family":"Dijk","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, University Medical Center Groningen, Beatrix Children's Hospital, University of Groningen, Groningen, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem P.","family":"de Boode","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Radboud University Medical Center, Radboud Institute for Health Sciences, Amalia Children's Hospital, Nijmegen, The Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinno","family":"Simons","sequence":"additional","affiliation":[{"name":"Department of Neonatal and Pediatric Intensive Care, Division of Neonatology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen P.","family":"Dijkman","sequence":"additional","affiliation":[{"name":"Department of Neonatology, M\u00e1xima Medical Center Veldhoven, Veldhoven, The Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrica L.M.","family":"van Straaten","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Isala Clinics, Zwolle, The Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Rijken","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Cools","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Vrije Universiteit Brussel, Brussels, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie H. G. M.","family":"Nuytemans","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton H.","family":"van Kaam","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuma. A.","family":"Bijleveld","sequence":"additional","affiliation":[{"name":"Department of Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron A. A.","family":"Math\u00f4t","sequence":"additional","affiliation":[{"name":"Department of Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the PharmaCool Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","article-title":"Hypoxic-ischemic encephalopathy: a review for the clinician","volume":"169","author":"Douglas-Escobar","year":"2015","journal-title":"JAMA Pediatr"},{"key":"R2-20250603","first-page":"99","article-title":"Current and emerging therapies in the management of hypoxic ischemic encephalopathy in neonates","volume":"5","author":"Nair","year":"2018","journal-title":"Children (Basel)"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2431-12-45","article-title":"Pharmacokinetics and pharmacodynamics of medication in asphyxiated newborns during controlled hypothermia. The PharmaCool multicenter study","volume":"12","author":"de Haan","year":"2012","journal-title":"BMC Pediatr"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1542\/peds.2012-0541","article-title":"Management of neonates with suspected or proven early-onset bacterial sepsis","volume":"129","author":"Polin","year":"2012","journal-title":"Pediatrics"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/tmi.12608","article-title":"Risk of gentamicin toxicity in neonates treated for possible severe bacterial infection in low- and middle-income countries: systematic review","volume":"20","author":"Musiime","year":"2015","journal-title":"Trop Med Int Health"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003088-200948020-00001","article-title":"Therapeutic drug monitoring of aminoglycosides in neonates","volume":"48","author":"Touw","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"e000685","DOI":"10.1136\/bmjpo-2020-000685","article-title":"Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review","volume":"4","author":"Lutz","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/bcp.12883","article-title":"Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia","volume":"81","author":"Bijleveld","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00003088-200847040-00002","article-title":"Facilitation of drug evaluation in children by population methods and modelling","volume":"47","author":"Tod","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11536750-000000000-00000","article-title":"Predictive performance of a recently developed population pharmacokinetic model for morphine and its metabolites in new datasets of (preterm) neonates, infants and children","volume":"50","author":"Krekels","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cpt.748","article-title":"Population pharmacokinetics of amoxicillin in term neonates undergoing moderate hypothermia","volume":"103","author":"Bijleveld","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/FTD.0000000000000056","article-title":"Predictive performance of a gentamicin population pharmacokinetic model in neonates receiving full-body hypothermia","volume":"36","author":"Sampson","year":"2014","journal-title":"Ther Drug Monit"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/phar.2186","article-title":"Population pharmacokinetics of gentamicin in neonates with hypoxemic-ischemic encephalopathy receiving controlled hypothermia","volume":"38","author":"Cies","year":"2018","journal-title":"Pharmacotherapy"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/phar.1263","article-title":"Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia","volume":"33","author":"Frymoyer","year":"2013","journal-title":"Pharmacotherapy"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jchromb.2014.01.035","article-title":"A simple quantitative method analysing amikacin, gentamicin, and vancomycin levels in human newborn plasma using ion-pair liquid chromatography\/tandem mass spectrometry and its applicability to a clinical study","volume":"951-952","author":"Bijleveld","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/psp4.12404","article-title":"NONMEM tutorial part I: description of commands and options, with simple examples of population analysis","volume":"8","author":"Bauer","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"e01304","DOI":"10.1128\/AAC.01304-16","article-title":"Population pharmacokinetics and dosing considerations for gentamicin in newborns with suspected or proven sepsis caused by gram-negative bacteria","volume":"61","author":"Bijleveld","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10928-009-9143-7","article-title":"Evaluation of different tests based on observations for external model evaluation of population analyses","volume":"37","author":"Brendel","year":"2010","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00003088-200746030-00003","article-title":"Are population pharmacokinetic and\/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004","volume":"46","author":"Brendel","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40262-020-00937-4","article-title":"Can population pharmacokinetics of antibiotics be extrapolated? Implications of external evaluations","volume":"60","author":"Cheng","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40262-023-01233-7","article-title":"External evaluation of population pharmacokinetic models for precision dosing: current state and knowledge gaps","volume":"62","author":"El Hassani","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/tropej\/fmi017","article-title":"Evaluation of renal functions in asphyxiated newborns","volume":"51","author":"Aggarwal","year":"2005","journal-title":"J Trop Pediatr"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3390\/pharmaceutics14102089","article-title":"Evaluating and improving neonatal gentamicin pharmacokinetic models using aggregated routine clinical care data","volume":"14","author":"Tong","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:16:45Z","timestamp":1748971005000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001166","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"2023-08-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}